Climate Change Data Portal
DOI | 10.1289/ehp.1205740 |
Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals | |
Aylward, Lesa L.1; Kirman, Christopher R.2; Schoeny, Rita3; Portier, Christopher J.4; Hays, Sean M.5 | |
发表日期 | 2013-03-01 |
ISSN | 0091-6765 |
卷号 | 121期号:3页码:287-294 |
英文摘要 | BACKGROUND: Biomonitoring data reported in the National Report on Human Exposure to Environmental Chemicals [NER; Centers for Disease Control and Prevention (2012)] provide information on the presence and concentrations of > 400 chemicals in human blood and urine. Biomonitoring Equivalents (BEs) and other risk assessment-based values now allow interpretation of these biomonitoring data in a public health risk context. OBJECTIVES: We compared the measured biomarker concentrations in the NER with BEs and similar risk assessment values to provide an across-chemical risk assessment perspective on the measured levels for approximately 130 analytes in the NER. METHODS: We identified available risk assessment-based biomarker screening values, including BEs and Human Biomonitoring-I (HBM-I) values from the German Human Biomonitoring Commission. Geometric mean and 95th percentile population biomarker concentrations from the NER were compared to the available screening values to generate chemical-specific hazard quotients (HQs) or cancer risk estimates. CONCLUSIONS: Most analytes in the NER show HQ values of < 1; however, some (including acrylamide, dioxin-like chemicals, benzene, xylene, several metals, di-2(ethylhexyl) phthalate, and some legacy organochlorine pesticides) approach or exceed HQ values of 1 or cancer risks of > 1 x 10(-4) at the geometric mean or 95th percentile, suggesting exposure levels may exceed published human health benchmarks. This analysis provides for the first time a means for examining population biomonitoring data for multiple environmental chemicals in the context of the risk assessments for those chemicals. The results of these comparisons can be used to focus more detailed chemical-specific examination of the data and inform priorities for chemical risk management and research. |
英文关键词 | biomonitoring;Biomonitoring Equivalents;blood;cancer risk;CDC National Exposure Report;hazard quotient;NHANES;risk assessment;urine |
语种 | 英语 |
WOS记录号 | WOS:000323703500018 |
来源期刊 | ENVIRONMENTAL HEALTH PERSPECTIVES
![]() |
来源机构 | 美国环保署 |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/58361 |
作者单位 | 1.Summit Toxicol LLP, Falls Church, VA 22044 USA; 2.Summit Toxicol LLP, Orange Village, OH USA; 3.US EPA, Off Res & Dev, Washington, DC 20460 USA; 4.Agcy Tox Subst & Dis Registry, Natl Ctr Environm Hlth, Atlanta, GA USA; 5.Summit Toxicol LLP, Lyons, CO USA |
推荐引用方式 GB/T 7714 | Aylward, Lesa L.,Kirman, Christopher R.,Schoeny, Rita,et al. Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals[J]. 美国环保署,2013,121(3):287-294. |
APA | Aylward, Lesa L.,Kirman, Christopher R.,Schoeny, Rita,Portier, Christopher J.,&Hays, Sean M..(2013).Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals.ENVIRONMENTAL HEALTH PERSPECTIVES,121(3),287-294. |
MLA | Aylward, Lesa L.,et al."Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals".ENVIRONMENTAL HEALTH PERSPECTIVES 121.3(2013):287-294. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。